Trend analysis on the disease burden among Chinese elderly population aged 60 and older from 1990 to 2019
WEI Xinyue and ZULIYAER Talifu contributed equally to this article
More Information
-
摘要:
目的 分析1990―2019年中国≥60岁老年人疾病负担变化趋势。 方法 利用2019年全球疾病负担数据库提供的中国≥60岁老年人伤残调整寿命年数据，使用该数据库提供的世界人口数作为标准对其进行标化，采用Joinpoint对数线性回归模型计算平均年度变化百分比，检验其长期变化趋势，分析1990―2019年中国≥60岁老年人疾病负担变化趋势。 结果 1990―2019年中国≥60岁老年人一级病因疾病负担均呈下降趋势，其中传染病所造成的疾病负担下降幅度最大，从1990年的6 079.32/10万下降到2019年的2 056.84/10万；非传染性疾病是造成老年人疾病负担的首要原因，2019年为71 694.02/10万。在三级病因中，结核病疾病负担下降幅度最大；2019年，脑卒中、缺血性心脏病和慢性阻塞性肺疾病，下呼吸道感染和结核病，跌倒、道路伤害和自杀分别是造成非传染性疾病、传染病和伤害疾病负担的主要原因。 结论 非传染性疾病和伤害日益成为中国急需解决的公共卫生问题。应加强对重点疾病(心脑血管疾病、恶性肿瘤、肌肉骨骼疾病等)以及重点人群(男性、≥85岁人群)的防控，通过管理健康风险因素及可改变的行为生活方式预防疾病发生，降低疾病负担。 Abstract:Objective To analyze the trends in the disease burden among Chinese individuals aged 60 years and older from 1990 to 2019. Methods The disability-adjusted life year (DALY) data for Chinese individuals aged 60 and older from the Global Burden of Disease 2019 database, were standardized using world population figures. Long-term trends were assessed using the average annual percent of change calculated by the Joinpoint log-linear regression model to evaluate changes in disease burden among elderly in China over the study period. Results Between 1990 and 2019, the disease burden for all level 1 causes among the elderly in China showed a decreasing trend. The most significant decline was observed in communicable diseases, with the burden decreasing from 6 079.32 per 100 000 in 1990 to 2 056.84 per 100 000 in 2019. Non-communicable diseases (NCDs) were the primary contributors to the disease burden among the elderly, with a rate of 71 694.02 per 100 000 in 2019. Among level 3 causes, tuberculosis showed the most substantial decline. In 2019, stroke, ischemic heart disease, and chronic obstructive pulmonary disease were the leading causes of NCDs; lower respiratory infections and tuberculosis were the main causes of communicable diseases; and falls, road injuries, and suicide were the primary causes of injury-related disease burden. Conclusions Non-communicable diseases and injuries are increasingly becoming urgent public health issues in China. It is essential to strengthen the prevention and control of key diseases (such as cardiovascular diseases, malignancy, and musculoskeletal diseases) and focus on vulnerable populations (men and ≥85-year-olds). Managing health risk factors and modifying lifestyles are crucial for preventing disease onset and reducing the overall disease burden. -
Key words:
- Elderly /
- Burden of disease /
- Disability-adjusted life years /
- Trend analysis
-
图 1 中国≥60岁老年人全病因和一级病因性别标化DALY率变化趋势
DALY，伤残调整寿命年。
Figure 1. Trends of standardized DALY rates of all cause and level 1 causes among Chinese people aged 60 years and older by gender
DALY, disability-adjusted life year.
图 2 中国≥60岁老年人全病因和一级病因年龄别标化DALY率变化趋势
DALY，伤残调整寿命年。
Figure 2. Trends of standardized DALY rates of all cause and level 1 causes among Chinese people aged 60 years and older by age group
DALY, disability-adjusted life year.
图 3 1990—2019年中国≥60岁老年人三级病因标化DALY率排名变化情况
DALY，伤残调整寿命年; 实线代表标化DALY率排名上升或不变，虚线代表标化DALY率排名下降。听力下降=与年龄相关的和其他听力下降。
Figure 3. Changes in rankings of standardized DALY rates of level 3 causes among Chinese people aged 60 years and older, 1990 to 2019
DALY, disabilit adjusted ife year; Solid lines are inreases or no changes in rank and dashed lies are decreases.Hearing loss =Age-related and other hearing loss.
表 1 中国≥60岁老年人疾病负担变化情况的性别Joinpoint回归分析
Table 1. Joinpoint regression analysis of changes in disease burden among Chinese people aged 60 years and older by gender
变量
Variable平均年度变化百分比 Average annual percent of change/%(95% CI) 全病因
All causes传染病、孕产妇和新生儿疾病、营养不良
Communicable, maternal, neonatal and nutritional diseases非传染性疾病
Non-commuicable diseases伤害
Injuries总体 Both -1.375①(-1.401~-1.350) -3.670①(-3.707~-3.630) -1.315①(-1.341~-1.290) -0.517①(-0.597~-0.445) 女性 Female -1.596①(-1.632~-1.560) -3.923①(-3.956~-3.887) -1.537①(-1.572~-1.502) -0.726①(-0.821~-0.619) 男性 Male -1.182①(-1.211~-1.154) -3.393①(-3.437~-3.346) -1.120①(-1.148~-1.092) -0.231①(-0.297~-0.173) 注：①P < 0.05。
Note: ① P < 0.05.
下载: 导出CSV
表 2 中国≥60岁老年人疾病负担变化情况的年龄别Joinpoint回归分析
Table 2. Joinpoint regression analysis of changes in disease burden among Chinese people aged 60 years and older by age group
年龄组/岁
Age group/years平均年度变化百分比 Average annual percent of change/%(95% CI) 全病因
All causes传染病、孕产妇和新生儿疾病、营养不良
Communicable, maternal, neonatal and nutritional diseases非传染性疾病
Non-commuicable diseases伤害
Injuries60~ < 65 -1.594①(-1.625~-1.565) -3.909①(-3.947~-3.859) -1.537①(-1.562~-1.513) -0.903①(-0.987~-0.822) 65~ < 70 -1.555①(-1.593~-1.521) -3.923①(-3.959~-3.879) -1.502①(-1.542~-1.468) -0.682①(-0.776~-0.595) 70~ < 75 -1.487①(-1.514~-1.460) -4.009①(-4.057~-3.961) -1.176①(-1.631~-0.708) -0.536①(-0.603~-0.457) 75~ < 80 -1.383①(-1.411~-1.352) -3.859①(-3.896~-3.820) -1.319①(-1.345~-1.288) -0.400①(-0.477~-0.321) 80~ < 85 -1.185①(-1.237~-1.128) -3.568①(-3.631~-3.490) -1.109①(-1.154~-1.057) -0.137①(-0.254~-0.035) 85~ < 90 -0.912①(-0.949~-0.873) -3.040①(-3.097~-2.986) -0.844①(-0.878~-0.808) 0.322①(0.271~0.373) 90~ < 95 -0.940①(-0.991~-0.890) -2.701①(-2.759~-2.639) -0.904①(-0.946~-0.860) 0.779①(0.723~0.831) ≥95 -0.787①(-0.829~-0.742) -2.301①(-2.339~-2.258) -0.629①(-0.854~-0.399) 1.537①(1.493~1.577) 注：①P < 0.05。
Note: ① P < 0.05.
下载: 导出CSV
-
[1] 王萍萍. 王萍萍: 人口总量有所下降人口高质量发展取得成效[N/OL]. 中国经济网, (2024-01-18)[2024-06-28]. http://www.ce.cn/xwzx/gnsz/gdxw/202401/18/t20240118_38870849.shtml .Wang PP. Wang Pingping: The total population has decreased, and high-quality development of the population has achieved results [N/OL]. China Economic Net, (2024-01-18) [2024-06-28].http://www.ce.cn/xwzx/gnsz/gdxw/202401/18/t20240118_38870849.shtml .[2] 刘晨, 王琼, 吴炳义, 等. 我国老年人口健康预期寿命变动分析——基于人口普查数据的实证研究[J]. 中国卫生政策研究, 2023, 16(2): 9-15. DOI: 10.3969/j.issn.1674-2982.2023.02.002.Liu C, Wang Q, Wu BY, et al. Analysis of changes in healthy life expectancy of elderly population in China: An empirical study based on census [J]. Chinese Journal of Health Policy, 2023, 16(2): 9-15. DOI: 10.3969/j.issn.1674-2982.2023.02.002. [3] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019 [J]. Lancet, 2020, 396(10258): 1223-1249. DOI: 10.1016/s0140-6736(20)30752-2. [4] Chen H, Chen G, Zheng X, et al. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study [J]. BMJ, 2019, 364: l969. DOI: 10.1136/bmj.l969. [5] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019 [J]. Lancet, 2020, 396(10258): 1204-1222. DOI: 10.1016/s0140-6736(20)30925-9. [6] Kim HJ, Chen HS, Midthune D, et al. Data-driven choice of a model selection method in Joinpoint regression [J]. J Appl Stat, 2023, 50(9): 1992-2013. DOI: 10.1080/02664763.2022.2063265. [7] 中华人民共和国国家卫生健康委员会宣传司. 国家卫生健康委员会2022年9月20日新闻发布会文字实录[C/OL]. (2022-09-20)[2024-01-16]. http://www.nhc.gov.cn/xcs/s3574/202209/ee4dc20368b440a49d270a228f5b0ac1.shtml .Department of Publicity, National Health Commission of the People′s Republic of China. Transcript of the press conference of the National Health Commission on September 20, 2022 [C/OL]. (2022-09-20) [2024-01-16].http://www.nhc.gov.cn/xcs/s3574/202209/ee4dc20368b440a49d270a228f5b0ac1.shtml .[8] Wu LX, Huang ZY, Pan ZH. The spatiality and driving forces of population ageing in China [J]. PLoS One, 2021, 16(1): e0243559. DOI: 10.1371/journal.pone.0243559. [9] Beard JR, Officer A, de Carvalho IA, et al. The World report on ageing and health: a policy framework for healthy ageing [J]. Lancet, 2016, 387(10033): 2145-2154. DOI: 10.1016/s0140-6736(15)00516-4. [10] Wang LD, Wang Y, Jin SG, et al. Emergence and control of infectious diseases in China [J]. Lancet, 2008, 372(9649): 1598-1605. DOI: 10.1016/S0140-6736(08)61365-3. [11] Zhou MG, Wang HD, Zeng XY, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017 [J]. Lancet, 2019, 394(10204): 1145-1158. DOI: 10.1016/S0140-6736(19)30427-1. [12] GBD 2019 LRI Collaborators. Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the global burden of dsease study 2019 [J]. Lancet Infect Dis, 2022, 22(11): 1626-1647. DOI: 10.1016/s1473-3099(22)00510-2. [13] 戴萌娜, 袭燕, 尹文强, 等. 1990—2019年中国结核病疾病负担现状及趋势分析[J]. 中国慢性病预防与控制, 2022, 30(10): 792-797. DOI: 10.16386/j.cjpccd.issn.1004-6194.2022.10.017.Dai MN, Gong Y, Yin WQ, et al. Analysis on the current situation and trend of tuberculosis disease burden in China from 1990 to 2019 [J]. Chin J Prev Contr Chron Dis, 2022, 30(10): 792-797. DOI: 10.16386/j.cjpccd.issn.1004-6194.2022.10.017. [14] 崔怡然, 宇传华. 基于全球视角下的中国结核病负担现状与趋势分析[J]. 中华疾病控制杂志, 2020, 24(3): 258-263, 283. DOI: 10.16462/j.cnki.zhjbkz.2020.03.003.Cui YR, Yu CH. Analysis on the status and trend of TB burden in China from the global views [J]. Chin J Dis Control Prev, 2020, 24(3): 258-263, 283. DOI: 10.16462/j.cnki.zhjbkz.2020.03.003. [15] 马圆, 韩萱, 马礼兵, 等. 下呼吸道感染疾病负担及影响因素研究进展[J]. 中华流行病学杂志, 2023, 44(2): 341-347. DOI: 10.3760/cma.j.cn112338-20220505-00383.Ma Y, Han X, Ma LB, et al. Research progress on disease burden and influencing factors of lower respiratory tract infection [J]. Chin J Epidemiol, 2023, 44(2): 341-347. DOI: 10.3760/cma.j.cn112338-20220505-00383. [16] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017 [J]. Lancet, 2018, 392(10159): 1789-1858. DOI: 10.1016/s0140-6736(18)32279-7. [17] Ruan Z, Qi J, Qian ZM, et al. Disease burden and attributable risk factors of respiratory infections in China from 1990 to 2019 [J]. Lancet Reg Health West Pac, 2021, 11: 100153. DOI: 10.1016/j.lanwpc.2021.100153. [18] The Lancet. Non-communicable diseases in China: a rising tide [J]. Lancet, 2023, 402(10417): 2045. DOI: 10.1016/s0140-6736(23)02691-0. [19] 《中国心血管健康与疾病报告2022》编写组. 《中国心血管健康与疾病报告2022》要点解读[J]. 中国心血管杂志, 2023, 28(4): 297-312. DOI: 10.3969/j.issn.1007-5410.2023.04.001.The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Interpretation of report on cardiovascular health and diseases in China 2022 [J]. Chin J Cardiovasc Med, 2023, 28(4): 297-312. DOI: 10.3969/j.issn.1007-5410.2023.04.001. [20] Xia CF, Dong XS, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants [J]. Chin Med J, 2022, 135(5): 584-590. DOI: 10.1097/cm9.0000000000002108. [21] Qiu HB, Cao SM, Xu RH. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 [J]. Cancer Commun, 2021, 41(10): 1037-1048. DOI: 10.1002/cac2.12197. [22] Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the global burden of disease study 2013 [J]. Lancet Neurol, 2016, 15(9): 913-924. DOI: 10.1016/S1474-4422(16)30073-4. [23] Ma QF, Li R, Wang LJ, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the global burden of disease study 2019 [J]. Lancet Public Health, 2021, 6(12): e897-e906. DOI: 10.1016/s2468-2667(21)00228-0. [24] Chen WQ, Xia CF, Zheng RS, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment [J]. Lancet Glob Health, 2019, 7(2): e257-e269. DOI: 10.1016/s2214-109x(18)30488-1. [25] Sun DQ, Li H, Cao MM, et al. Cancer burden in China: trends, risk factors and prevention [J]. Cancer Biol Med, 2020, 17(4): 879-895. DOI: 10.20892/j.issn.2095-3941.2020.0387. [26] 侯珊珊, 施劲东, 尹欣, 等. 1990-2019年中国慢性阻塞性肺疾病的疾病负担情况分析[J]. 中华流行病学杂志, 2022, 43(10): 1554-1561. DOI: 10.3760/cma.j.cn112338-20211009-00773.Hou SS, Shi JD, Yin X, et al. Disease burden of chronic obstructive pulmonary diseases in China from 1990 to 2019 [J]. Chin J Epidemiol, 2022, 43(10): 1554-1561. DOI: 10.3760/cma.j.cn112338-20211009-00773. [27] 戴振威, 杨悦, 付佳琪, 等. 群医学及全球健康研究进展及启示[J]. 中华疾病控制杂志, 2023, 27(11): 1336-1341. DOI: 10.16462/j.cnki.zhjbkz.2023.11.015.Dai ZW, Yang Y, Fu JQ, et al. Research progress and implications of population medicine and global health [J]. Chin J Dis Control Prev, 2023, 27(11): 1336-1341. DOI: 10.16462/j.cnki.zhjbkz.2023.11.015. [28] Ruthsatz M, Candeias V. Non-communicable disease prevention, nutrition and aging [J]. Acta Biomed, 2020, 91(2): 379-388. DOI: 10.23750/abm.v91i2.9721. [29] 付朝伟. 阿尔茨海默病重在预防——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(1): 8-11. DOI: 10.16150/j.1671-2870.2022.01.003.Fu CW. Alzheimer′s disease focuses on prevention - "China alzheimer′s disease report 2021" [J]. J Diagn Concepts Pract, 2022, 21(1): 8-11. DOI: 10.16150/j.1671-2870.2022.01.003. [30] 徐勇, 王军, 王虹峥, 等. 2023中国阿尔茨海默病数据与防控策略[J]. 阿尔茨海默病及相关病杂志, 2023, 6(3): 175-192. DOI: 10.3969/j.issn.2096-5516.2023.03.001.Xu Y, Wang J, Wang HZ, et al. 2023 data and strategies of prevention and control for alzheimer′s disease in China [J]. Chin J Alzheimers Dis Relat Disord, 2023, 6(3): 175-192. DOI: 10.3969/j.issn.2096-5516.2023.03.001. [31] Sharma RK, Chern A, Golub JS. Age-related hearing loss and the development of cognitive impairment and late-life depression: a scoping overview [J]. Semin Hear, 2021, 42(1): 10-25. DOI: 10.1055/s-0041-1725997. [32] Cieza A, Causey K, Kamenov K, et al. Global estimates of the need for rehabilitation based on the global burden of disease study 2019: a systematic analysis for the global burden of disease study 2019 [J]. Lancet, 2021, 396(10267): 2006-2017. DOI: 10.1016/S0140-6736(20)32340-0. [33] 皮书说. 报告精读|听力健康蓝皮书: 中国听力健康报告(2021) [R/OL]. (2021-11-11)[2024-03-16]. https://www.pishu.cn/zxzx/xwdt/574203.shtml .Pishu Shuo. Report reading | blue book of hearing health: report on hearing health in China (2021) [R/OL]. (2021-11-11) [2024-03-16].https://www.pishu.cn/zxzx/xwdt/574203.shtml .[34] Chen NJ, Fong DYT, Wong JYH. Trends in musculoskeletal rehabilitation needs in China from 1990 to 2030: a bayesian age-period-cohort modeling study [J]. Front Public Health, 2022, 10: 869239. DOI: 10.3389/fpubh.2022.869239. [35] World Health Organization. Falls [EB/OL]. (2021-04-26) [2024-02-24]. https://www.who.int/news-room/fact-sheets/detail/falls .[36] 国家卫生健康委疾病预防控制局. 预防老年人跌倒健康教育核心信息[EB/OL]. (2021-10-12)[2024-03-15]. https://www.chinacdc.cn/jkzt/mxfcrjbhsh/jcysj/202110/t20211012_250181.html .[37] 陆治名, 汪媛, 叶鹏鹏, 等. 2015-2018年全国伤害监测系统中老年人跌倒/坠落病例分布特征[J]. 中华流行病学杂志, 2021, 42(1): 137-141. DOI: 10.3760/cma.j.cn112338-20200424-00646.Lu ZM, Wang Y, Ye PP, et al. Analysis on epidemiologic characteristics of fall in old people: results from Chinese National Injury Surveillance System, 2015-2018 [J]. Chin J Epidemiol, 2021, 42(1): 137-141. DOI: 10.3760/cma.j.cn112338-20200424-00646. [38] 张聪颖, 耳玉亮, 叶鹏鹏, 等. 2020年中国老年人伤害死亡特征分析[J]. 中国健康教育, 2022, 38(11): 968-972. DOI: 10.16168/j.cnki.issn.1002-9982.2022.11.002.Zhang CY, Er YL, Ye PP, et al. Analysis on the characteristics of injury deaths among the elderly in China, 2020 [J]. Chinese Journal of Health Education, 2022, 38(11): 968-972. DOI: 10.16168/j.cnki.issn.1002-9982.2022.11.002. [39] Azami-Aghdash S, Aghaei MH, Sadeghi-Bazarghani H. Epidemiology of road traffic injuries among elderly people; a systematic review and meta-analysis [J]. Bull Emerg Trauma, 2018, 6(4): 279-291. DOI: 10.29252/beat-060403. [40] 中国疾病预防控制中心. 最新世界卫生统计: 中国人均预期寿命77.4岁, 4类慢病导致过早死亡[EB/OL]. (2022-07-01)[2024-02-23]. https://www.chinacdc.cn/gwxx/202207/t20220707_260045.html .[41] 王素贤, 蒋帅, 赵要军, 等. 2004-2021年我国居民主要伤害死亡率变化趋势[J]. 中华疾病控制杂志, 2024, 28(3): 249-255 DOI: 10.16462/j.cnki.zhjbkz.2024.03.001.Wang SX, Jiang S, Zhao YJ, et al. The trend of injury mortality rates among Chinese residents from 2004 to 2021 [J]. Chin J Dis Control Prev, 2024, 28(3): 249-255. DOI: 10.16462/j.cnki.zhjbkz.2024.03.001. [42] 陈岱云, 陈希. 社会性别视域下的人口寿命性别差异分析[J]. 山东大学学报(哲学社会科学版), 2022, (6): 97-107. DOI: 10.19836/j.cnki.37-1100/c.2022.06.009.Chen DY, Chen X. Analysis of gender differences in life expectancy from the perspective of gender [J]. Journal of Shandong University Philosophy and Social Sciences, 2022, (6): 97-107. DOI: 10.19836/j.cnki.37-1100/c.2022.06.009. [43] GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017 [J]. Lancet, 2018, 392(10159): 1923-1994. DOI: 10.1016/s0140-6736(18)32225-6. [44] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013 [J]. Lancet, 2015, 385(9963): 117-171. DOI: 10.1016/s0140-6736(14)61682-2. [45] Patwardhan V, Gil GF, Arrieta A, et al. Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the global burden of disease study 2021 [J]. Lancet Public Health, 2024, 9(5): e282-e294. DOI: 10.1016/s2468-2667(24)00053-7. [46] Fan JX, Wen M, Jin L, et al. Disparities in healthcare utilization in China: do gender and migration status matter? [J]. J Fam Econ Iss, 2013, 34(1): 52-63. DOI: 10.1007/s10834-012-9296-1. [47] Redondo-Sendino A, Guallar-Castillón P, Banegas JR, et al. Gender differences in the utilization of health-care services among the older adult population of Spain [J]. BMC Public Health, 2006, 6: 55. DOI: 10.1186/1471-2458-6-155. [48] Iburg KM, Charalampous P, Allebeck P, et al. Burden of disease among older adults in Europe-trends in mortality and disability, 1990-2019 [J]. Eur J Public Health, 2023, 33(1): 121-126. DOI: 10.1093/eurpub/ckac160. -
点击查看大图
图(3) / 表(2)
计量
- 文章访问数: 225
- HTML全文浏览量: 48
- PDF下载量: 35
- 被引次数: 0